butyric acid has been researched along with clozapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Aoyama, Y; Ikawa, N; Koseki, T; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Narusawa, S; Toriumi, K; Yamada, K | 1 |
1 review(s) available for butyric acid and clozapine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
1 other study(ies) available for butyric acid and clozapine
| Article | Year |
|---|---|
Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor.
Topics: Animals; Antipsychotic Agents; Benzazepines; Butyric Acid; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Clozapine; Dopamine Antagonists; Epigenesis, Genetic; Exploratory Behavior; Hallucinogens; Haloperidol; Histamine Antagonists; Histone Deacetylases; Histones; Male; Memory Disorders; Mice; Mice, Inbred ICR; Phencyclidine; Phencyclidine Abuse; Prefrontal Cortex; Receptors, Dopamine D1 | 2014 |